Your browser doesn't support javascript.
loading
A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.
Ruan, Qiu T; Yazdani, Neema; Blum, Benjamin C; Beierle, Jacob A; Lin, Weiwei; Coelho, Michal A; Fultz, Elissa K; Healy, Aidan F; Shahin, John R; Kandola, Amarpreet K; Luttik, Kimberly P; Zheng, Karen; Smith, Nathaniel J; Cheung, Justin; Mortazavi, Farzad; Apicco, Daniel J; Ragu Varman, Durairaj; Ramamoorthy, Sammanda; Ash, Peter E A; Rosene, Douglas L; Emili, Andrew; Wolozin, Benjamin; Szumlinski, Karen K; Bryant, Camron D.
Afiliação
  • Ruan QT; Biomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Yazdani N; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Blum BC; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.
  • Beierle JA; Biomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Lin W; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Coelho MA; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.
  • Fultz EK; Center for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Healy AF; Biomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Shahin JR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Kandola AK; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.
  • Luttik KP; Center for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Zheng K; Department of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
  • Smith NJ; Department of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
  • Cheung J; Department of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
  • Mortazavi F; Department of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
  • Apicco DJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Ragu Varman D; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Ramamoorthy S; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Ash PEA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Rosene DL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Emili A; Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Wolozin B; Laboratory of Neurodegeneration, Department of Pharmacology and Experimental Therapeutics and Neurology, Boston University School of Medicine, Boston, Massachusetts 02118.
  • Szumlinski KK; Department of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, Virginia 23284, and.
  • Bryant CD; Department of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, Virginia 23284, and.
J Neurosci ; 40(1): 107-130, 2020 01 02.
Article em En | MEDLINE | ID: mdl-31704785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reforço Psicológico / Recompensa / Sinaptossomos / Dopamina / Ribonucleoproteínas Nucleares Heterogêneas / Ribonucleoproteínas Nucleares Heterogêneas Grupo F-H / Metanfetamina / Mitocôndrias Limite: Animals Idioma: En Revista: J Neurosci Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reforço Psicológico / Recompensa / Sinaptossomos / Dopamina / Ribonucleoproteínas Nucleares Heterogêneas / Ribonucleoproteínas Nucleares Heterogêneas Grupo F-H / Metanfetamina / Mitocôndrias Limite: Animals Idioma: En Revista: J Neurosci Ano de publicação: 2020 Tipo de documento: Article